• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的虚拟筛选发现新型丁酰胆碱酯酶抑制剂。

Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.

机构信息

a College of Pharmacy, Al Ain University of Science and Technology , Abu Dhabi , UAE.

b Department of Chemistry, College of Science, UAE University , Al-Ain , UAE.

出版信息

J Enzyme Inhib Med Chem. 2019 Dec;34(1):1373-1379. doi: 10.1080/14756366.2019.1644329.

DOI:10.1080/14756366.2019.1644329
PMID:31347933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6711031/
Abstract

Butyrylcholinesterase (BChE) plays an important role in the progression of the Alzheimer's disease. In this study, we used a structure-based virtual screening (VS) approach to discover new BChE inhibitors. A ligand database was filtered and docked to the BChE protein using Glide program. The outcome from VS was filtered and the top ranked hits were thoroughly examined for their fitting into the protein active site. Consequently, the best 38 hits were selected for testing using Ellman's method, and six of which showed inhibition activity for BChE. Interestingly, the most potent hit (Compound 4) exhibited inhibitory activity against the BChE enzyme in the low micromolar level with an IC50 value of 8.3 µM. Hits obtained from this work can act as a starting point for future SAR studies to discover new BChE inhibitors as anti-Alzheimer agents.

摘要

丁酰胆碱酯酶(BChE)在阿尔茨海默病的发展中起着重要作用。在这项研究中,我们使用基于结构的虚拟筛选(VS)方法来发现新的 BChE 抑制剂。使用 Glide 程序筛选配体数据库并对接 BChE 蛋白。从 VS 中筛选出的结果,并对排名最高的命中进行了深入检查,以了解它们是否适合蛋白质的活性部位。因此,选择了最好的 38 个命中进行 Ellman 法测试,其中 6 个显示出对 BChE 的抑制活性。有趣的是,最有效的命中(化合物 4)以低微摩尔水平显示出对 BChE 酶的抑制活性,IC50 值为 8.3µM。从这项工作中获得的命中可以作为未来 SAR 研究的起点,以发现新的 BChE 抑制剂作为抗阿尔茨海默病药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a75b/6711031/217bf113dec8/IENZ_A_1644329_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a75b/6711031/f0b6b6f44735/IENZ_A_1644329_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a75b/6711031/f669f4eb4866/IENZ_A_1644329_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a75b/6711031/406af274ac0b/IENZ_A_1644329_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a75b/6711031/217bf113dec8/IENZ_A_1644329_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a75b/6711031/f0b6b6f44735/IENZ_A_1644329_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a75b/6711031/f669f4eb4866/IENZ_A_1644329_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a75b/6711031/406af274ac0b/IENZ_A_1644329_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a75b/6711031/217bf113dec8/IENZ_A_1644329_F0004_C.jpg

相似文献

1
Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.基于结构的虚拟筛选发现新型丁酰胆碱酯酶抑制剂。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1373-1379. doi: 10.1080/14756366.2019.1644329.
2
Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation.扩展支架多样性以开发高选择性丁酰胆碱酯酶 (BChE) 抑制剂:通过药效团模型生成、虚拟筛选和分子动力学模拟发现新的苗头化合物。
Bioorg Chem. 2019 Apr;85:117-127. doi: 10.1016/j.bioorg.2018.12.023. Epub 2018 Dec 21.
3
Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations.通过计算研究和生物学评估的结合发现选择性丁酰胆碱酯酶(BChE)抑制剂。
Molecules. 2019 Nov 20;24(23):4217. doi: 10.3390/molecules24234217.
4
Discovery, biological evaluation and molecular dynamic simulations of butyrylcholinesterase inhibitors through structure-based pharmacophore virtual screening.通过基于结构的药效团虚拟筛选发现、评价和分子动力学模拟丁酰胆碱酯酶抑制剂。
Future Med Chem. 2021 May;13(9):769-784. doi: 10.4155/fmc-2020-0325. Epub 2021 Mar 24.
5
Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.基于药效团的 AChE 和 BChE 双重抑制剂的药物设计作为潜在的抗阿尔茨海默病药物。
Bioorg Chem. 2021 Sep;114:105149. doi: 10.1016/j.bioorg.2021.105149. Epub 2021 Jul 7.
6
Discovery, molecular dynamic simulation and biological evaluation of structurally diverse cholinesterase inhibitors with new scaffold through shape-based pharmacophore virtual screening.通过基于形状的药效团虚拟筛选,发现、分子动力学模拟和对具有新骨架的结构多样的胆碱酯酶抑制剂的生物评估。
Bioorg Chem. 2019 Nov;92:103294. doi: 10.1016/j.bioorg.2019.103294. Epub 2019 Sep 19.
7
Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-Aβ Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation.新型选择性丁酰胆碱酯酶(BChE)抑制剂的发现及其抗 Aβ 聚集活性:基于结构的虚拟筛选、命中优化和生物学评价。
Molecules. 2019 Jul 15;24(14):2568. doi: 10.3390/molecules24142568.
8
Search for new multi-target compounds against Alzheimer's disease among histamine H receptor ligands.寻找组胺 H 受体配体中针对阿尔茨海默病的新型多靶化合物。
Eur J Med Chem. 2020 Jan 1;185:111785. doi: 10.1016/j.ejmech.2019.111785. Epub 2019 Oct 17.
9
Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening.基于结构的虚拟筛选快速发现选择性丁酰胆碱酯酶抑制剂。
Bioorg Med Chem Lett. 2020 Dec 15;30(24):127609. doi: 10.1016/j.bmcl.2020.127609. Epub 2020 Oct 8.
10
Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.吡啶磺酰胺作为一种小分子有机药物,具有治疗 II 型糖尿病和阿尔茨海默病的潜力:体外研究对抗酵母 α-葡萄糖苷酶、乙酰胆碱酯酶和丁酰胆碱酯酶。
Bioorg Chem. 2015 Dec;63:64-71. doi: 10.1016/j.bioorg.2015.09.008. Epub 2015 Sep 30.

引用本文的文献

1
Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer's Disease.用于治疗阿尔茨海默病的乙酰胆碱酯酶和单胺氧化酶-B双重抑制剂
Molecules. 2025 Jul 15;30(14):2975. doi: 10.3390/molecules30142975.
2
Pharmacological Evaluation of a Traditional Thai Polyherbal Formula for Alzheimer's Disease: Evidence from In Vitro and In Silico Studies.一种用于治疗阿尔茨海默病的泰国传统多草药配方的药理学评估:来自体外和计算机模拟研究的证据。
Int J Mol Sci. 2025 Jun 29;26(13):6287. doi: 10.3390/ijms26136287.
3
Kaempferia parviflora extract and its methoxyflavones as potential anti-Alzheimer assessing in vitro, integrated computational approach, and in vivo impact on behaviour in scopolamine-induced amnesic mice.

本文引用的文献

1
Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screening.通过药效团和基于结构的虚拟筛选鉴定Mdm2-p53相互作用的新型抑制剂。
Drug Des Devel Ther. 2018 Nov 2;12:3741-3752. doi: 10.2147/DDDT.S182444. eCollection 2018.
2
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.用于治疗阿尔茨海默病的选择性丁酰胆碱酯酶抑制剂鉴定方面的最新进展。
Eur J Med Chem. 2017 May 26;132:294-309. doi: 10.1016/j.ejmech.2017.03.062. Epub 2017 Mar 27.
3
Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.
山柰提取物及其甲氧基黄酮作为潜在抗阿尔茨海默病药物的体外评估、综合计算方法以及对东莨菪碱诱导的记忆缺失小鼠行为的体内影响
PLoS One. 2025 Mar 10;20(3):e0316888. doi: 10.1371/journal.pone.0316888. eCollection 2025.
4
Identification of potential inhibitors of cholinergic and β-secretase enzymes from phytochemicals derived from Gongronema latifolium Benth leaf: an integrated computational analysis.从 Gongronema latifolium Benth 叶的植物化学物质中鉴定胆碱能和β-分泌酶抑制剂:综合计算分析。
Mol Divers. 2024 Jun;28(3):1305-1322. doi: 10.1007/s11030-023-10658-y. Epub 2023 Jun 20.
5
Anti-AChE and Anti-BuChE Screening of the Fermentation Broth Extracts from Twelve Aspergillus Isolates and GC-MS and Molecular Docking Studies of the Most Active Extracts.十二株曲霉发酵液提取物的抗 AChE 和抗 BuChE 筛选及活性最强提取物的 GC-MS 和分子对接研究。
Appl Biochem Biotechnol. 2023 Aug;195(8):5199-5216. doi: 10.1007/s12010-023-04548-0. Epub 2023 May 2.
6
In Vitro and In Silico Investigation of Polyacetylenes from (Spreng.) Dandy as Potential COX-2, 5-LOX, and BchE Inhibitors.体外和计算机研究来自 (Spreng.)Dandy 的多炔类化合物作为潜在的 COX-2、5-LOX 和 BchE 抑制剂。
Molecules. 2023 Apr 17;28(8):3526. doi: 10.3390/molecules28083526.
7
New Thienobenzo/Naphtho-Triazoles as Butyrylcholinesterase Inhibitors: Design, Synthesis and Computational Study.新型噻吩并苯并三唑类丁酰胆碱酯酶抑制剂的设计、合成与计算研究。
Int J Mol Sci. 2023 Mar 20;24(6):5879. doi: 10.3390/ijms24065879.
8
Anticholinesterase activity of : and green synthesis approach in search for therapeutic agents against Alzheimer's disease.的抗胆碱酯酶活性以及用于寻找抗阿尔茨海默病治疗药物的绿色合成方法。
Front Pharmacol. 2022 Nov 4;13:1044248. doi: 10.3389/fphar.2022.1044248. eCollection 2022.
9
Epigenetic Mechanisms of Postoperative Cognitive Impairment Induced by Anesthesia and Neuroinflammation.麻醉和神经炎症引起术后认知障碍的表观遗传机制。
Cells. 2022 Sep 21;11(19):2954. doi: 10.3390/cells11192954.
10
Pharmacophore based virtual screening of cholinesterase inhibitors: search of new potential drug candidates as antialzheimer agents.基于药效团的胆碱酯酶抑制剂虚拟筛选:寻找作为抗阿尔茨海默病药物的新潜在候选药物。
In Silico Pharmacol. 2022 Sep 29;10(1):18. doi: 10.1007/s40203-022-00133-1. eCollection 2022.
氧化应激、突触功能障碍与阿尔茨海默病
J Alzheimers Dis. 2017;57(4):1105-1121. doi: 10.3233/JAD-161088.
4
Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening.基于结构的虚拟筛选发现高选择性丁酰胆碱酯酶抑制剂及其构效关系
J Med Chem. 2016 Aug 25;59(16):7683-9. doi: 10.1021/acs.jmedchem.6b00356. Epub 2016 Jul 26.
5
The synthesis of some β-lactams and investigation of their metal-chelating activity, carbonic anhydrase and acetylcholinesterase inhibition profiles.一些β-内酰胺的合成及其金属螯合活性、碳酸酐酶和乙酰胆碱酯酶抑制谱的研究。
J Enzyme Inhib Med Chem. 2016;31(sup1):79-88. doi: 10.3109/14756366.2016.1170014. Epub 2016 Apr 13.
6
Synthesis of some tetrahydropyrimidine-5-carboxylates, determination of their metal chelating effects and inhibition profiles against acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase.一些四氢嘧啶-5-羧酸盐的合成、它们对金属的螯合作用以及对乙酰胆碱酯酶、丁酰胆碱酯酶和碳酸酐酶的抑制作用研究
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1531-9. doi: 10.3109/14756366.2016.1156104. Epub 2016 Mar 28.
7
Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase.异吲哚酮曼尼希碱对碳酸酐酶、乙酰胆碱酯酶和丁酰胆碱酯酶的抑制作用。
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1498-501. doi: 10.3109/14756366.2016.1149479. Epub 2016 Mar 1.
8
Alzheimer's disease: Targeting the Cholinergic System.阿尔茨海默病:靶向胆碱能系统
Curr Neuropharmacol. 2016;14(1):101-15. doi: 10.2174/1570159x13666150716165726.
9
Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?神经退行性变与阿尔茨海默病(AD)。蛋白质组学能告诉我们关于阿尔茨海默病大脑的哪些信息?
Mol Cell Proteomics. 2016 Feb;15(2):409-25. doi: 10.1074/mcp.R115.053330. Epub 2015 Dec 11.
10
The effect of caffeic acid phenethyl ester (CAPE) on metabolic enzymes including acetylcholinesterase, butyrylcholinesterase, glutathione S-transferase, lactoperoxidase, and carbonic anhydrase isoenzymes I, II, IX, and XII.咖啡酸苯乙酯(CAPE)对包括乙酰胆碱酯酶、丁酰胆碱酯酶、谷胱甘肽S-转移酶、乳过氧化物酶以及碳酸酐酶同工酶I、II、IX和XII在内的代谢酶的影响。
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1095-101. doi: 10.3109/14756366.2015.1094470. Epub 2015 Oct 9.